The FDA said yesterday it will relax its review of some genetic tests that examine millions of different variants at the same time, and finalised two guidances designed to enhance collaboration among researchers, and drive the efficient development of novel NGS-based tests.
The advancement of sequencing technology has had the singe biggest effect on genomics research. As it develops further, so does the scope of genomic research and applications.
Illumina and Loxo Oncology have announced a global strategic partnership to develop a diagnostic tool that will work with Loxo’s larotrectinib and another of its experimental cancers drugs, across tumour types.
Critically ill infants in the Australian state of Victoria are now to be given access to rapid genomic sequencing under a new government-funded programme.
Comparison of Single Nucleotide Variants in Sequencing Data Produced by Illumina and Oxford Nanopore Technologies.
Come hear from David Grieg, Bioinformatician at Public Health England to learn more about the application of the MinION for the surveillance of Shiga toxin-producing Escherichia coli O157:H7.
Introducing our new webinar series, The Genome Spot. Each month we’ll be picking the brains of some of the leading researchers, to uncover some of the key movements, challenges and solutions in the field.
For the first time, researchers have been able to use long read nanopore sequencing to assemble the genomic sequence of a human Y chromosome centromere.
UK-based genomics data platform Global Gene Corp and American genetics company, Regeneron Genetics Center announced yesterday that they will collaborate to create the world’s largest project of its kind to study Indian population.
Dame Sally Davies insists that learning more about a patient’s genetic makeup will lead to a better and more cost-effective approach, that will ultimately spare resources in the system.
GenomeAsia 100k are trying to close the genetic gap that exists in the South Asian population, by seeking to sequence 100 genomes from the region.